# Pharmaceutics International, Inc. - Inspection Records Source: https://www.keypedia.com/companies/pharmaceutics-international-inc/38fdf7bd-a7f3-486e-b74d-13b87414922e > Inspection records and compliance data for Pharmaceutics International, Inc. in Cockeysville, Maryland. Access full analysis and detailed observations. --- ## Details - Name: Pharmaceutics International, Inc. - FEI Number: 3006503102 - City: Cockeysville - State: Maryland - Country Name: United States - Address Line 1: 103 Beaver Ct - Zip Code: 21030 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE ## Related Documents - [FDA Inspection 1307080 - Pharmaceutics International, Inc. - 2026-03-06](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/357b9f0b-0f0d-44ec-abbf-4c4b6f1cde63) — source: FDA, date: March 6, 2026 - [FDA Inspection 1244595 - Pharmaceutics International, Inc. - 2024-06-12](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/03e8a1ed-759e-4088-ab01-dfca099336fb) — classification: No Action Indicated (NAI), source: FDA, date: June 12, 2024 - [483 - Pharmaceutics International, Inc. - 2022-11-14](https://www.keypedia.com/records/483/pharmaceutics-international-inc/937931f6-45c4-44ee-8b03-39ff1917c695) — source: FDA, date: November 14, 2022 - [EIR - Pharmaceutics International, Inc. - 2022-11-14](https://www.keypedia.com/records/eir/pharmaceutics-international-inc/ef206f73-a4e1-444d-aae9-d09577c023c9) — source: FDA, date: November 14, 2022 - [FDA Inspection 1194409 - Pharmaceutics International, Inc. - 2022-11-14](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/c233b238-eb27-4d58-99dc-abe21668f706) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 14, 2022 - [EIR - Pharmaceutics International, Inc. - 2021-09-29](https://www.keypedia.com/records/eir/pharmaceutics-international-inc/6073937e-d251-478b-9d02-6fc098e85b25) — source: FDA, date: September 29, 2021 - [483 - Pharmaceutics International, Inc. - 2021-09-29](https://www.keypedia.com/records/483/pharmaceutics-international-inc/98c0fefd-6d0c-4a86-ac7d-593085f5d47e) — source: FDA, date: September 29, 2021 - [FDA Inspection 1155191 - Pharmaceutics International, Inc. - 2021-09-29](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/43f67413-7ec6-43f4-8e2f-d7e656fddbdd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2021 - [483 - Pharmaceutics International, Inc. - 2020-10-30](https://www.keypedia.com/records/483/pharmaceutics-international-inc/b1b883c2-e23c-45a1-9762-e36d6a7222af) — source: FDA, date: October 30, 2020 - [EIR - Pharmaceutics International, Inc. - 2020-07-10](https://www.keypedia.com/records/eir/pharmaceutics-international-inc/ff6926d1-b00a-402d-8253-8e5e18aad5bc) — source: FDA, date: July 10, 2020 - [483 - Pharmaceutics International, Inc. - 2020-07-10](https://www.keypedia.com/records/483/pharmaceutics-international-inc/1f4d0f6f-9d88-4271-9537-82cbb1c04111) — source: FDA, date: July 10, 2020 - [FDA Inspection 1124545 - Pharmaceutics International, Inc. - 2020-07-10](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/90031451-63db-47ab-818c-858e417991d1) — classification: No Action Indicated (NAI), source: FDA, date: July 10, 2020 - [EIR - Pharmaceutics International, Inc. - 2018-11-09](https://www.keypedia.com/records/eir/pharmaceutics-international-inc/d380df3c-197b-499a-b180-1cdd078bcf5e) — source: FDA, date: November 9, 2018 - [FDA Inspection 1072073 - Pharmaceutics International, Inc. - 2018-11-09](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/f3ba1bae-6f2d-49d8-ad30-c59d2fe1ee3b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2018 - [FDA Inspection 1072073 - Pharmaceutics International, Inc. - 2018-11-09](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/92acb046-607f-4e37-bc30-7fbf6fb7e4bc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2018 - [483 - Pharmaceutics International, Inc. - 2017-10-27](https://www.keypedia.com/records/483/pharmaceutics-international-inc/1072b5e6-ef5e-404d-a0b3-54063b982137) — source: FDA, date: October 27, 2017 - [FDA Inspection 1030024 - Pharmaceutics International, Inc. - 2017-10-27](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/04041c07-f2d3-4e40-a675-591ed7369620) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 27, 2017 - [483 - Pharmaceutics International, Inc. - 2016-04-04](https://www.keypedia.com/records/483/pharmaceutics-international-inc/6fb09bb0-c571-4f95-9373-92e75ada3ab8) — source: FDA, date: April 4, 2016 - [FDA Inspection 966612 - Pharmaceutics International, Inc. - 2016-04-04](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/92a54a3e-e216-4fca-ba9d-96a97541f6d9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 4, 2016 - [FDA Inspection 943321 - Pharmaceutics International, Inc. - 2015-05-29](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/ae91122a-361d-4872-8289-b940047254b8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 29, 2015 ## Related Companies - [Panacea Biotec Pharma Limited](https://www.keypedia.com/companies/panacea-biotec-pharma-limited/47335546-7299-440b-8c05-623c8b44b99b) - [LSNE Madison LLC](https://www.keypedia.com/companies/lsne-madison-llc/97b52716-6508-4868-9609-761c6bc02db4) - [SpecGx, LLC](https://www.keypedia.com/companies/specgx-llc/ee069c18-3128-4bbe-9c13-768b4837810f) - [Aurobindo Pharma Limited](https://www.keypedia.com/companies/aurobindo-pharma-limited/526fd1b4-90b1-4e91-b9f5-a3eab997ed60) - [Catalent Pharma Solutions LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/1080c7fd-2536-4ea5-9a11-18fc6317081b) - [Lilly del Caribe, Inc](https://www.keypedia.com/companies/lilly-del-caribe-inc/5091d4cf-a496-46ba-96aa-da9dbb686073) - [Sun Pharmaceuticals Industries Ltd.](https://www.keypedia.com/companies/sun-pharmaceuticals-industries-ltd/758af0ba-71ed-4144-b6c7-e175eaafa473) - [Nippon Fine Chemical Co., Ltd.](https://www.keypedia.com/companies/nippon-fine-chemical-co-ltd/6b21c73b-4779-42c3-b0f6-64179f8de3a2) - [Chugai Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/chugai-pharmaceutical-co-ltd/5261bb2e-233a-40e3-8aa3-3e7b0b70dd29) - [BRS Analytical Services, LLC](https://www.keypedia.com/companies/brs-analytical-services-llc/841b237e-76fe-4854-a862-802339b3e528) ## Related Officers - [Investigator](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1) - [investigator](https://www.keypedia.com/people/rachael-oyewole/bc642edb-4124-4cd1-b979-0d752ead1bfd) - [Kathleen M. Jordan, Investigator](https://www.keypedia.com/people/kathleen-m-jordan-investigator/a7780ec0-4958-4cf3-acab-6f1b37785e76) - [Shirehendu K. Deb, Investigator](https://www.keypedia.com/people/shirehendu-k-deb-investigator/91920e54-6b95-4366-b2e1-abf44c97585b) - [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae) - [Investigator](https://www.keypedia.com/people/edmund-f-mrak/a43cf86a-c020-4948-bff6-358b2453908a)